5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
Data up to Jan 2025
Total Citations Per Year
Abstract
References (50)
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
1989 • 1,313 citations
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
1989 • 600 citations
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
1988 • 548 citations
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
1987 • 526 citations
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
1987 • 455 citations
Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
1987 • 451 citations
The concept of selectivity in 5-HT receptor research
1990 • 425 citations
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain
1986 • 354 citations
Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors
1976 • 350 citations
Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices
1986 • 312 citations
In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
1987 • 301 citations
Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release
1989 • 277 citations
Neuropharmacology of Serotonin
1989 • 268 citations
Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition
1989 • 266 citations
Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration
1988 • 255 citations
Regulation of monoamine metabolism in the central nervous system.
1972 • 241 citations
Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
1986 • 225 citations
An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat
1977 • 210 citations
The dorsal and medial raphe projections to the substantia nigra in the rat: Electrophysiological, biochemical and behavioural observations
1978 • 208 citations
Serotonergic inhibition of catecholamine-induced behavioral arousal
1973 • 200 citations
Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release
1989 • 191 citations
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
1988 • 186 citations
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate
1991 • 143 citations
8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis
1988 • 126 citations
Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysis
1990 • 114 citations
Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA
1990 • 114 citations
Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system
1976 • 111 citations
Differential effects of Para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy
1976 • 97 citations
Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences
1987 • 94 citations
Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: Comparison of injection sites
1978 • 92 citations
Neurotoxicity of MDMA: Neurochemical Effects
1990 • 86 citations
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine
1990 • 86 citations
Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
1988 • 79 citations
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
1991 • 78 citations
5‐HT2 Receptors, Roles and Regulation
1990 • 63 citations
Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
1990 • 61 citations
Effect of 3,4‐Methylenedioxymethamphetamine on 3,4‐Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens
1990 • 56 citations
5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
1992 • 45 citations
Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys
1989 • 41 citations
Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5‐HT2 receptors
1988 • 39 citations
Recreational Use of MDMA
1990 • 38 citations
Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats
1989 • 37 citations
Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings
1987 • 34 citations
(±)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons
1989 • 31 citations
Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation
1981 • 29 citations
Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine
1986 • 23 citations
Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle
1990 • 21 citations
Involvement of serotonin in mediation of inhibition of substantia nigra neurons by noxious stimuli
1989 • 11 citations
Evidence for a functional coupling between dopamine reuptake and tyrosine hydroxylation in striatal nerve terminals
1982 • 7 citations
The neurobiology of schizophrenia
1991 • 5 citations